India's Sun Pharma to buy US-listed Organon in about $11.8 billion deal - Reuters
India's Sun Pharma to buy US-listed Organon in about $11.8 billion deal Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"Organon's portfolio, capabilities and global reach are highly complementary to our own, and we believe that bringing the two organizations together can create a stronger and more diversified platform."
— Dilip Shanghvi , Executive
"This transaction represents a significant opportunity for Sun Pharma. Organon’s portfolio, capabilities and global reach are highly complementary to our own."
— Dilip Shanghvi , Executive
"Organon’s portfolio, capabilities and global reach are highly complementary to our own, and we believe that bringing the two organisations together can create a stronger and more diversified platform."
— Dilip Shanghvi , Executive
"Organon’s portfolio, capabilities and global reach are highly complementary to our own, and we believe that bringing the two organizations together can create a stronger and more diversified platform."
— Dilip Shanghvi , Executive
Key People
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOT0Y4NFc5aDZpdXQxOFJuZmRGaGF3NE5hSnQ3bEIxNy1WQ2J4LVVRY3JVWHBOMGxiZGRzNlFKOUxReVFvTnBJSkJJRkhkd3laS1BEaEg4Q190X3pSYkp5b3Y4RXo3RlZqVTlZcUdnYVFXMTMzaFpoc3FwckliTkUzeUdNV054cHNKb3dFNjlzX1g2S2JRNHFwRFR4U0dEQm1qb0ZZa3V0T0c2eHA3REQtWkVDZGdXLW5EUHdLdnJ3?oc=5" target="_blank">India's Sun Pharma to buy US-listed Organon in about $11.8 billion deal</a> <font color="#6f6f6f">Reuters</font>
Sun Pharmaceutical Industries has agreed to acquire Organon & Co in an all-cash deal valued at approximately $11.75 billion, with Organon shareholders set to receive $14.00 per share.
Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years.
Sun Pharmaceutical Industries Ltd. has agreed to acquire New York-listed women’s health-care company Organon & Co., expanding its global reach with one of the biggest outbound deals by an Indian company.
Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy Organon & Co. in a transaction valuing the New York-listed healthcare company at $11.8 billion.
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the US drugmaker at about US$11.75 billion including debt, in one of India’s biggest outbound deals.
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the U.S. drugmaker at about $11.75 billion, including debt.
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the US drugmaker at about $11.75 billion including debt, in one of India's biggest outbound deals.
Sun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion, including debt.
Similar Stories
Related coverage based on topic and tags
Canada's Weston family to buy UK's Boots in $8.9 billion deal - Reuters
Canada's Weston family to buy UK's Boots in $8.9 billion deal Reuters
October 7, 2026 at 04:53 PMIndia's Aditya Birla unit seeks $1.5 billion in rupee loans to buy Shell arm Solenergi, bankers say - Reuters
India's Aditya Birla unit seeks $1.5 billion in rupee loans to buy Shell arm Solenergi, bankers say Reuters
October 9, 2026 at 06:08 AMMcKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters
October 6, 2026 at 04:30 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMBASF considers raising offer for Evonik, sources say - Reuters
BASF considers raising offer for Evonik, sources say Reuters
October 9, 2026 at 02:02 PMUK pharmacy chain Boots sold in $8.9bn deal to Canadian billionaire family
The sale of the High Street chain was announced on Wednesday.
October 7, 2026 at 05:18 PM